scispace - formally typeset
M

Mary J. Roman

Researcher at Cornell University

Publications -  371
Citations -  51574

Mary J. Roman is an academic researcher from Cornell University. The author has contributed to research in topics: Blood pressure & Population. The author has an hindex of 100, co-authored 365 publications receiving 48687 citations. Previous affiliations of Mary J. Roman include University of Maryland, Baltimore & NewYork–Presbyterian Hospital.

Papers
More filters
Journal Article

Left ventricular geometry and arterial function in hypercholesterolemia.

TL;DR: Hypercholesterolemia in normotensive non-diabetic adults is independently associated with a mildly concentric LV geometry and a reduced index of total arterial compliance.
Journal ArticleDOI

The effect of nitrous oxide on left ventricular pump performance and contractility in patients with coronary artery disease: effect of preoperative ejection fraction.

TL;DR: To elucidate the effects of nitrous oxide (N2O) on left ventricular (LV) pump performance and contractility, 28 patients undergoing coronary artery bypass graft surgery were studied, of whom 15 had depressed global LV function at preoperative catheterization.
Journal ArticleDOI

Prevalence and correlates of rheumatic heart disease in American Indians (the Strong Heart Study).

TL;DR: The Strong Heart Study (SHS) assessed the prevalence and correlates of chronic rheumatic heart disease (RHD) in American Indians as discussed by the authors and found that this population may have a high prevalence of RHD.
Journal ArticleDOI

Accelerated atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.

TL;DR: It is important for primary care physicians to recognise rheumatoid arthritis and systemic lupus erythematosus patients as high‐risk groups for atherosclerosis, requiring aggressive risk‐factor modification.
Journal ArticleDOI

C-Reactive Protein and Electrocardiographic ST-Segment Depression Additively Predict Mortality: The Strong Heart Study

TL;DR: The combination of ECG STD and CRP increases the risk of mortality, demonstrating the additive impacts of active inflammation and preclinical CVD on prognosis.